Pure Global
ANZCTR12623001115628

Small drop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in preterm infants

Pilot randomised controlled trial for small drop administration device in preterm infants for retinopathy of prematurity eye examinations
University of Otago·Not Applicable·Australian New Zealand Clinical Trials Registry·device·Device trialNot yet recruiting
Study focus
Disease/Condition
Retinopathy of Prematurity
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Otago
Location
New Zealand
Timeline & enrollment
Phase
Not Applicable
Start date
Nov 13, 2023
End date
Feb 29, 2024
Primary outcome

Successful retinopathy of prematurity eye examination

Summary

To date, there has not been an evaluation of a suitable device to administer microdoses to preterm infants. The nanodrop eye drop device has been evaluated in adults and children, but not yet evaluated in preterm infants.

ICD-10 classifications
Retinopathy of prematurityOther proliferative retinopathyBackground retinopathy and retinal vascular changesDiabetic retinopathyRetinal disorder, unspecified
Data source
Registry
Australian New Zealand Clinical Trials Registry
Trial ID
ANZCTR12623001115628
Type
Device Trial
About this record

Access comprehensive clinical trial information for ANZCTR12623001115628 through Pure Global AI's free database. This Not Applicable trial is sponsored by University of Otago and is currently Not yet recruiting. The study focuses on Retinopathy of Prematurity.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.